Electronic medication compliance monitoring system and associated methods

• US 9,047,746 B1
• Filed: 09/14/2010
• Issued: 06/02/2015
• Est. Priority Date: 07/20/2005
• Status: Active Grant

• Current Assignee: Etectrx Incorporated
• Original Assignee: Neil Euliano
• Inventors: Myers, Brent A., Principe, Jose C., Euliano, Neil R. II, Meka, Venkata V., Flores, Glen
• Primary Examiner(s): Nguyen, Hung T
• Application Number:
  US12/881,572
• Time in Patent Office: 1,722 Days
• Field of Search: 340/572.1, 340/572.7, 340/572.9, 340/573.1, 340/572.4, 340/539.12, 340/286.07, 340/10.1, 340/10.3, 600/3, 600/309, 600/300, 600/301, 600/302, 600/407, 600/411, 128/903, 128/904
• US Class Current: 1/1
• CPC Class Codes: A61B 2560/0209 adapted for power saving
• CPC Class Codes: A61B 2560/0214 of power generation or supply
• CPC Class Codes: A61B 5/065 Determining position of the probe employing exclusively positioning means located on or in the probe, e.g. using position sensors arranged on the probe
• CPC Class Codes: A61B 5/07 Endoradiosondes
• CPC Class Codes: A61B 5/073 Intestinal transmitters
• CPC Class Codes: A61B 5/14539 for measuring pH
• CPC Class Codes: A61B 5/285 Endotracheal, oesophageal or gastric probes
• CPC Class Codes: A61B 5/42 Detecting, measuring or recording for evaluating the gastrointestinal, the endocrine or the exocrine systems A61B1/00, A61B5/4857, A61B5/486, A61B5/4866, A61B5/4869 take precedence
• CPC Class Codes: A61B 5/4833 Assessment of subject's compliance to treatment
• CPC Class Codes: A61M 2205/3592 using telemetric means, e.g. radio or optical transmission
• CPC Class Codes: G08B 23/00 Alarms responsive to unspecified undesired or abnormal conditions
• CPC Class Codes: G16H 20/10 relating to drugs or medications, e.g. for ensuring correct administration to patients
• CPC Class Codes: G16H 20/13 delivered from dispensers
• CPC Class Codes: G16H 40/67 for remote operation
• CPC Class Codes: G16H 70/40 relating to drugs, e.g. their side effects or intended usage

Abstract

A system and method for monitoring a patient'"'"'s compliance with a medication regimen includes an electronic tag integral with or attached to a medicine delivery device such as a capsule, the tag having an antenna and a receiver/transmitter, the system also including a reader positioned externally for detecting the presence and location of the delivery device in the patient.

Claims

1. An electronic system for monitoring a patient'"'"'s compliance with a medication program, the system comprising:

an electronic reader adapted to be positioned externally adjacent the patient, the reader having means for transmitting first in-link radio frequency signals and for receiving and processing second out-link radio frequency signals;

an ingestible medicine delivery device;

a tag fitted with the delivery device; and

an active tag electronic circuit carried by the tag, the circuit having means for receiving the in-link signals from the reader and means for transmitting the out-link signals to the reader to indicate the presence of the delivery device within the patient'"'"'s body.

2. The electronic medication monitoring system recited in claim 1 wherein the frequency of the out-link signals from the electronic circuit is at least one order of magnitude greater than the frequency of the in-link signals from the electronic reader.

3. The electronic medication monitoring system recited in claim 2 wherein the electronic circuit comprises an integrated circuit having an in-link signal receiving antenna, an out-link signal transmitting antenna, and means for electronically isolating the in-link signal antenna from the out-link signal antenna.

4. The electronic medication monitoring system recited in claim 1 wherein the delivery device comprises a capsule having an outer surface and an inner surface, with the tag fitted to one of the inner and outer surfaces.

5. The electronic medication monitoring system recited in claim 1, wherein the in-link signals are conductive through the patient'"'"'s body and the out-link signals are radiative through and outside the patient'"'"'s body.

6. The electronic medication monitoring system recited in claim 2 wherein the in-link signals are in the frequency range of between about one-twenty megahertz and the out-link signals are in a range between about 200-600 megahertz.

7. The electronic medication monitoring system recited in claim 1 wherein the active electronic circuit comprises means for harvesting energy in the patient'"'"'s body for use in transmitting the out-link signals to the electronic reader.

8. The electronic medication monitoring system recited in claim 7, wherein the harvesting means harvests energy for a period that is substantially longer than each transmission of the out-link signals.

9. The electronic medication monitoring system recited in claim 1 further comprising means for transmitting the out-link signals in data bursts synchronized with the in-link signals.

10. The electronic medication monitoring system recited in claim 1 wherein the out-link signals are coded with data representing at least one of the patient'"'"'s identification, an identification for a medication trial, a medication type, signal strength of the in-link signals at the tag, and elapsed time of the tag in the patient'"'"'s gastrointestinal tract.

11. The electronic medication monitoring system recited in claim 1 wherein the reader comprises means for receiving and processing out-link signals from multiple tags simultaneously within the patient'"'"'s body.

12. The electronic medication monitoring system recited in claim 1 further comprising:

a capsule;

an electrically insulative substrate fitted with the capsule and having an upper surface and an opposing lower surface;

antenna means disposed across one of the substrate surfaces and electrically coupled to the tag electronic circuit for receiving the in-link signals and transmitting the out-link signals to the reader; and

the tag electronic circuit fitted to one of the surfaces of the substrate, the tag circuit having means for emitting the out-link signals as an output representing at least one of the identification of the tag, the location of the tag and information regarding the tag'"'"'s surroundings.

13. The electronic medication monitoring system recited in claim 12 wherein the substrate comprises a portion elongated in at least one direction beyond the tag electronic circuit, with the antenna disposed along one of the surfaces of the elongated portion.

14. The electronic medication monitoring system recited in claim 13 wherein at least the elongated portion is flexible, permitting the substrate to be fitted around a curved surface of the capsule.

15. The electronic tag recited in claim 12 further comprising a coating over the tag electronic circuit and the antenna that is impervious to the liquid in the tag'"'"'s environment.

16. The electronic tag recited in claim 7 further comprising a coating over the antenna that dissolves in the presence of the liquid in the tag'"'"'s environment.

17. The electronic tag recited in claim 12 further comprising multiple coatings over the tag circuit and the antenna, each coating dissolvable under predetermined conditions in the tag'"'"'s environment.

18. The electronic tag recited in claim 12 wherein the capsule has a curved outer surface and a curved inner surface;

and wherein the substrate is flexible and is dimensioned to fit along one of the curved surfaces of the capsule.

19. The electronic medication monitoring system recited in claim 16 wherein the coating, the substrate and the antenna are all ingestible, non-toxic and biodegradable.

20. The electronic medication monitoring system recited in claim 12 wherein the electronic circuit is ingestible and non-toxic.

21. The electronic medication monitoring system recited in claim 12 wherein the antenna means comprises a deposited layer of one of a non-toxic silver-containing compound and a carbon-containing compound.

22. The electronic medication monitoring system recited in claim 1 wherein the electronic reader comprises:

a transmitter for transmitting the in-link signals to the tag electronic circuit;

a receiver for receiving the out-link signals from the tag electronic circuit; and

means for processing data received in the out-link signals.

23. The electronic medication monitoring system recited in claim 22 further comprising a phase-lock loop circuit for synchronizing the in-link and out-link signals.

24. The electronic medication monitoring system recited in claim 22 further comprising means for transmitting processed data from the out-link signals to a remote data receiving unit.

25. The electronic medication monitoring system recited in claim 22 further comprising means for indicating the patient'"'"'s compliance with a medication program.

26. The electronic medication monitoring system recited in claim 22 wherein the electronic reader further comprises means in external physical contact within the patient.

27. The electronic medication monitoring system recited in claim 26 wherein the external physical contact means comprises one of a wristband, a patch or a container.

28. The electronic medication monitoring system recited in claim 1 further comprising means fitted on the tag and electronically coupled to activate the tag electronic circuit when the medicine delivery device has been ingested.

29. The electronic medication monitoring system recited in claim 28 wherein the activation means comprises a galvanic sensor.

30. The electronic medication monitoring system recited in claim 28 wherein the activation means comprises a bio-switch having a portion that swells in the presence of gastric fluids.

31. An ingestible electronic tag for use in tracking ingested medication in a patient'"'"'s body, the tag comprising:

an electrically insulated substrate having an upper surface and an opposing lower surface;

a tag electronic circuit fitted to one of the surfaces of the substrate, the tag circuit having means for receiving in-link signals, harvesting energy from the patient'"'"'s body and then transmitting out-link signals containing data representative of the status of the tag and its location; and

antenna means disposed across one of the substrate surfaces and electrically coupled to the tag electronic circuit for receiving the in-link signals and transmitting the out-link signals.

32. The ingestible electronic tag recited in claim 31 further comprising:

a capsule having a curved outer surface and a curved inner surface; and

wherein

the substrate is flexible and is dimensioned to fit along one of the curved surfaces of the capsule.

33. The ingestible electronic tag recited in claim 31 wherein the in-link signals are conductive and the out-link signals are radiative.

34. The ingestible electronic tag recited in claim 31 further comprising phase-lock loop means for synchronizing the in-link and out-link signals.

35. The ingestible electronic tag recited in claim 31 wherein the substrate comprises an ingestible coated paper, and wherein the coating and the paper dissolve in the presence of predetermined gastric fluids.

36. The ingestible electronic tag recited in claim 31 further comprising a galvanic gastric sensor fitted with the tag and coupled with the tag electronic circuit, the sensor providing varying inputs to the tag electronic circuit dependent upon location of the sensor in the patient'"'"'s body.

37. The ingestible electronic tag recited in claim 36 wherein the galvanic gastric sensor comprises first and second spaced ingestible metal strips that are together galvanically active, with an ingestion detector between the strips to measure an electrical output when a galvanic reaction occurs between the metal strips.

38. The ingestible electronic tag recited in claim 37 wherein the first metal strip is formed of silver phosphate and the second metal strip is formed of zinc.

39. The ingestible electronic tag recited in claim 37 further comprising a dissolvable coating over each metal strip.

40. The ingestible electronic tag recited in claim 37 wherein the output of the ingestible detector powers the tag electronic circuit.

41. The ingestible electronic tag recited in claim 37 further comprising:

a capsule formed of two interconnecting parts; and

means for installing the tag electronic circuit within the capsule and fitting the antenna means along the exterior of the capsule.

42. The ingestible electronic tag recited in claim 31 further comprising an electronic reader adapted to be positioned adjacent the patient'"'"'s body, the reader having a transmitter for transmitting the in-link signals conductively to the tag electronic circuit and a receiver for receiving and processing radiative transmissions of the out-link signals from the tag electronic circuit.

43. The ingestible electronic tag recited in claim 42 further comprising means defining an out-link protocol adapted to improve signal detection by the electronic reader.

44. The ingestible electronic tag recited in claim 43 further comprising means at the electronic reader for controlling the out-link protocol means via the in-link signals.

45. The ingestible electronic tag recited in claim 44 further comprising:

means in the tag electronic circuit for determining the strength of received in-link signals and transmitting that signal strength to the electronic reader via the out-link signals; and

means with the electronic reader for controlling the out-link protocol based upon in-link signal strength.

46. The ingestible electronic tag recited in claim 42 further comprising means for correlating the reader with the tag to insure that the out-link signals are being received from the correct patient.

47. The ingestible electronic tag recited in claim 31 further comprising means within the tag electronic circuit for harvesting energy from the patient'"'"'s body and using the harvested energy to transmit the out-link signals.

48. The ingestible electronic tag recited in claim 47 wherein the tag electronic circuit comprises means for suspending transmission of the out-link signals until sufficient energy has been stored to resume those transmissions.

49. A method for monitoring a patient'"'"'s compliance with a medication program, the method comprising the steps of:

positioning an electronic reader adjacent the patient, the reader having means for transmitting capacitive in-link signals through the patient'"'"'s body and for receiving and processing radiative out-link signals from the patient'"'"'s body;

fitting a medicine delivery device ingestible by the patient with a tag having an active electronic circuit with means for receiving the capacitive in-link signals and transmitting the radiative out-link signal; and

having the patient ingest the capsule and thereafter activating the electronic circuit to permit transmission of the radiative out-link signals to the electronic reader so as to indicate the patient'"'"'s compliance with the medication program.

50. The method recited in claim 49 further comprising the step of harvesting energy from the patient'"'"'s body and using the harvested energy to transmit the out-link signals.